US stock · US markets · public data

ABBV

Abbvie Inc · Healthcare

Reference price$283.49Updated according to the public source
P/E80.08
P/B-84.40
ROE—
DY 12M2.41%
Net margin—
Net debt/equity—
Market capUS$ 501.0 B
Volume (shares)2,901,855
SectorHealthcare
Overview

About ABBV

Demonstrações públicas consolidadas + SEC Company Facts

Abbvie Inc (ABBV) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
09/23
12/23
03/24
06/24
09/24
12/24
03/25
06/25
09/25
12/25
03/26
06/26
Income in shown records$19.43
DY 12M2.41%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$1.73
Period ending 2026-03-31Dividendo declarado$1.73
Period ending 2025-12-31Dividendo declarado$1.73
Period ending 2025-09-30Dividendo declarado$1.64
Period ending 2025-06-30Dividendo declarado$1.64
Period ending 2025-03-31Dividendo declarado$1.64

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$54,318,000,000.00$56,334,000,000.00$61,160,000,000.00—
Operating Income$12,757,000,000.00$9,137,000,000.00$15,075,000,000.00—
Net Income$4,863,000,000.00$4,278,000,000.00$4,226,000,000.00—
EPS Diluted$2.72 / share$2.39 / share$2.36 / share—

Balance sheet

Account2023202420252026
Total Assets$134,711,000,000.00$135,161,000,000.00$133,960,000,000.00—
Total Equity$10,360,000,000.00$3,325,000,000.00-$3,270,000,000.00—
Long-term Debt$59,245,000,000.00$66,841,000,000.00$64,503,000,000.00—
Current Debt$0.00$0.00$2,499,000,000.00—
Shares Outstanding1,769,399,971 shares1,766,473,359 shares1,765,354,859 shares1,768,169,012 shares
Cash & Investments$13,120,000,000.00$5,834,000,000.00$5,525,000,000.00—
Dívida Líquida$46,125,000,000.00$61,007,000,000.00$61,477,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$22,839,000,000.00$18,806,000,000.00$19,030,000,000.00—
Capital Expenditures$777,000,000.00$974,000,000.00$1,214,000,000.00—
Dividends Paid$10,539,000,000.00$11,025,000,000.00$11,657,000,000.00—
Free Cash Flow$22,062,000,000.00$17,832,000,000.00$17,816,000,000.00—
FAQ

Frequently asked questions

What is the price of ABBV?

The reference price available for ABBV is $283.49.

What is the P/E of ABBV?

The P/E ratio of ABBV is 80.08. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of ABBV?

The P/B of ABBV is -84.40. This compares price with reported book value per share.

What is the dividend yield of ABBV?

The dividend yield of ABBV is 2.41%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of ABBV?

The market capitalization of ABBV is US$ 501.0 B.

What sector is ABBV in?

ABBV operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.